These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 3140452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts].
    Chatenoud L, Bach JF.
    Nephrologie; 1987; 8(3):95-8. PubMed ID: 3309702
    [Abstract] [Full Text] [Related]

  • 4. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U, Frei D, Keusch G, Burger HR, Largiader F, Binswanger U.
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
    Monaco A, Goldstein G, Barnes L.
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.
    Waid TH, Lucas BA, Thompson JS, Munch LC, Brown S, Kryscio R, Prebeck R, VanHoy MA, Jezek D.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1062-5. PubMed ID: 1899152
    [No Abstract] [Full Text] [Related]

  • 9. Immunologic monitoring in OKT3-treated kidney graft recipients.
    Zlabinger GJ, Maurer D, Ulrich W, Meron G, Pohanka E, Kovarik J.
    Transplant Proc; 1990 Aug; 22(4):1777-8. PubMed ID: 2117807
    [No Abstract] [Full Text] [Related]

  • 10. Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection.
    Georgitis JW, Browning MC, Steiner D, Lorentz WB.
    Ann Allergy; 1991 Apr; 66(4):343-7. PubMed ID: 1901692
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies.
    Colvin RB, Preffer FI.
    Clin Lab Med; 1991 Sep; 11(3):693-714. PubMed ID: 1934971
    [Abstract] [Full Text] [Related]

  • 13. A U.S. clinical study of Orthoclone OKT3 in renal transplantation.
    Norman DJ, Shield CF, Barry J, Henell K, Funnell MB, Lemon J.
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):21-7. PubMed ID: 3105136
    [No Abstract] [Full Text] [Related]

  • 14. Reversing cardiac transplant rejection with Orthoclone OKT3.
    Dault LA, Nagy CS, Collins JA.
    Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Orthoclone OKT3 (Muromonab CD3)--the indications for and manner of its use. Side effects and their prevention].
    Filev A, Kumanov Kh, Slavov Ch, Tsvetkov M.
    Khirurgiia (Sofiia); 1989 Jul; 42(6):80-2. PubMed ID: 2517512
    [Abstract] [Full Text] [Related]

  • 17. Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use.
    Emmons C, Hunsicker LG.
    Iowa Med; 1987 Feb; 77(2):78-82. PubMed ID: 3557906
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.
    Norman DJ, Shield CF, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M.
    Transplantation; 1988 Oct; 46(4):523-9. PubMed ID: 3140448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.